2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
22
Neoplasms
20
Leukemia, Myeloid, Acute
10
Ovarian Neoplasms
8
Neoplasm Metastasis
7
Lymphoma
7
Lung Neoplasms
7
Hematologic Neoplasms
6
Glioblastoma
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Multiple Myeloma
5
Leukemia
5
Fatigue
5
Stomach Neoplasms
4
Depression
4
Carcinoma, Non-Small-Cell Lung
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pain
3
Myelodysplastic Syndromes
3
Motor Activity
3
Melanoma
3
Fallopian Tube Neoplasms
3
Carcinoma, Hepatocellular
3
Interventions
Bevacizumab
4
Temozolomide
3
Irinotecan
3
Sorafenib
2
Radiosurgery
2
pembrolizumab
1
ibrutinib
1
Vorinostat
1
Valproic Acid
1
Transcranial Magnetic Stimulation
1
Therapeutics
1
Thalidomide
1
Surveys and Questionnaires
1
Standard of Care
1
Sildenafil Citrate
1
Radiotherapy
1
Pliability
1
Plasma Exchange
1
Palliative Care
1
Nivolumab
1
Morphine
1
Methadone
1
Lenalidomide
1
Laparoscopy
1
Immunoglobulins
1
Exercise
1
Equipment and Supplies
1
Eating
1
Cytidine Triphosphate
1
Clomipramine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neurologic Manifestations
×
Palliative Care
×
Clear all
NCT07590726
2026-05-19
PIRe
Rigshospitalet, Denmark
Phase NA
Not yet recruiting
160 enrolled